Boston Scientific Corp (BSX)vsCapsoVision, Inc. Common Stock (CV)
BSX
Boston Scientific Corp
$51.71
+0.53%
HEALTHCARE · Cap: $71.14B
CV
CapsoVision, Inc. Common Stock
$6.79
-1.02%
HEALTHCARE · Cap: $344.75M
Smart Verdict
WallStSmart Research — data-driven comparison
Boston Scientific Corp generates 154704% more annual revenue ($21.00B vs $13.56M). BSX leads profitability with a 17.5% profit margin vs -198.9%. BSX earns a higher WallStSmart Score of 72/100 (B).
BSX
Strong Buy72
out of 100
Grade: B
CV
Avoid14
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-31.7%
Fair Value
$39.04
Current Price
$51.71
$12.67 premium
Intrinsic value data unavailable for CV.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Large-cap with strong market position
Growing faster than its price suggests
Reasonable price relative to book value
Strong operational efficiency at 22.9%
Generating 1.3B in free cash flow
Conservative balance sheet, low leverage
Areas to Watch
Distress zone — elevated risk
Trading at 16.6x book value
0.3% revenue growth
0.0% earnings growth
Smaller company, higher risk/reward
Comparative Analysis Report
WallStSmart ResearchBull Case : BSX
The strongest argument for BSX centers on Market Cap, PEG Ratio, Price/Book. Profitability is solid with margins at 17.5% and operating margin at 22.9%. PEG of 0.67 suggests the stock is reasonably priced for its growth.
Bull Case : CV
The strongest argument for CV centers on Debt/Equity.
Bear Case : BSX
The primary concerns for BSX are Altman Z-Score.
Bear Case : CV
The primary concerns for CV are Price/Book, Revenue Growth, EPS Growth.
Key Dynamics to Monitor
BSX profiles as a mature stock while CV is a turnaround play — different risk/reward profiles.
BSX is growing revenue faster at 7.5% — sustainability is the question.
BSX generates stronger free cash flow (1.3B), providing more financial flexibility.
Monitor MEDICAL DEVICES industry trends, competitive dynamics, and regulatory changes.
Bottom Line
BSX scores higher overall (72/100 vs 14/100), backed by strong 17.5% margins. Both earn "Strong Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Boston Scientific Corp
HEALTHCARE · MEDICAL DEVICES · USA
Boston Scientific Corporation, doing business as Boston Scientific, is a manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology.
CapsoVision, Inc. Common Stock
HEALTHCARE · MEDICAL DEVICES · USA
CapsoVision, Inc., a medical technology company, manufactures and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal system. The company is headquartered in Saratoga, California.
Visit Website →Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?